Study to Evaluate Treatment Customized According to RAP80 and BRCA1 in Patients With Advanced Lung Carcinoma

Clinical trial NCT00617656 · TERMINATED

Trial details

NCT number: NCT00617656
Sponsor: Spanish Lung Cancer Group
Status: TERMINATED
Phase: Phase 3
Study type: INTERVENTIONAL

Non Small Cell Lung Cancer BRCA1 Mutation

Start date: 2008-02-01
Primary completion: 2015-04-01
Enrollment: 382

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.